Hybrid plasminogen activators with improved thrombolytic properties and drugs comprising these plasminogen activators
    1.
    发明公开
    Hybrid plasminogen activators with improved thrombolytic properties and drugs comprising these plasminogen activators 失效
    混合型纤溶酶原激活剂血小板凝集素Eigenschaften und diese Plasminogenaktivatoren enthaltende Medikamente。

    公开(公告)号:EP0275606A1

    公开(公告)日:1988-07-27

    申请号:EP87202610.9

    申请日:1987-12-22

    IPC分类号: C12N15/00 C12N9/72 A61K37/54

    摘要: The invention relates to plasminogen activators obtained by expression of fused cDNA encoding fragments of human tissue-type plasminogen activator (t-PA) and of human urokinase-type plasminogen activator (u-PA), by combining the fibrin-affinity of t-PA with the fibrin-specificity of u-PA in the single chain form (scu-PA) and,or with the enzymatic activity of u-PA having the two-chain form (tcu-PA). It is preferably a hybrid molecule obtained by fusion of at least a region part of the NHz-terminal region of t-PA to at least a part region of the COOH-terminal region of scu-PA, most preferably the NH 2 -terminal amino acids 1 to 263 of t-PA, fused to the COOH-terminal amino acids 144 to 411 of scu-PA.
    The invention relates further to a recombinant DNA molecule which yields said hybrid plasminogen activators; the respective mammalian expression vector containing said DNA sequence; a transfected mammalian cell line which comprises said recombinant DNA molecule; and to the method for the preparation of plasminogen activators.

    摘要翻译: 本发明涉及通过表达编码人组织型纤溶酶原激活物(t-PA)和人尿激酶型纤溶酶原激活物(u-PA)片段的融合cDNA获得的纤溶酶原激活物,通过结合t-PA的纤维蛋白亲和力 其中u-PA在单链形式(scu-PA)中的纤维蛋白特异性和/或具有双链形式(tcu-PA)的u-PA的酶活性。 优选通过将t-PA的NH 2末端区域的至少一部分区域与scu-PA的COOH末端区域的至少一部分区域融合而得到的杂合分子,最优选NH 2末端氨基酸 1至263的t-PA,与scu-PA的COOH末端氨基酸144至411融合。 本发明还涉及产生所述杂合纤溶酶原激活物的重组DNA分子; 含有所述DNA序列的各个哺乳动物表达载体; 包含所述重组DNA分子的转染的哺乳动物细胞系; 以及制备纤溶酶原激活物的方法。